Riskpilot← Back to searchSign inGet full accessORLMED AS
ASActiveOrg 924791381Flåtanstien 9, 3413 LierMedical specialists activities · NACE 8622Est. 20202 employees
Revenue 2025
NOK 9,8M
-3% vs 2024
EBITDA margin
20.9%
-15% vs 2024
Equity ratio
9.8%
Financial strength
Net profit 2025
NOK 1,3M
-14% vs 2024
| Revenue | NOK 9,8M | -3% |
| EBITDA | NOK 2M | -15% |
| Net profit | NOK 1,3M | -14% |
| Total assets | NOK 3,8M | -9% |
| Equity | NOK 370K | +17% |
| Employees | 2 | — |
Legal name
ORLMED AS
Org number
924791381
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
18. mars 2020
Share capital
NOK 30 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Company purpose
Helsetjenester innen øre, nese og hals og andre produkter/tjenester som naturlig hører til dette, herunder å delta i andre selskap med lignende virksomhet, og kjøp og salg av aksjer eller på annen måte gjøre seg interessert i andre foretak. Selskapet kan også drive med kjøp/drift av fast eiendom.
Address
Flåtanstien 9, 3413 Lier
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 6 707 | 7 093 | 9 261 | 10 138 | 9 816 |
| Staff expenses | −1 805 | −2 671 | −3 929 | −3 822 | −3 856 |
| EBITDA | 2 325 | 1 441 | 1 644 | 2 416 | 2 050 |
| Depreciation & amort. | −599 | −850 | −501 | −392 | −355 |
| EBIT | 1 726 | 590 | 1 143 | 2 023 | 1 695 |
| Net financials | −223 | −215 | −189 | −145 | −86 |
| Profit before tax | 1 502 | 375 | 954 | 1 879 | 1 609 |
| Tax | 332 | 83 | 209 | 414 | 355 |
| Net profit | 1 170 | 293 | 744 | 1 465 | 1 254 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 5 323 | 4 676 | 4 438 | 4 165 | 3 783 |
| Equity | 342 | 607 | 51 | 316 | 370 |
| Long-term debt | 4 279 | 3 300 | 1 823 | 1 172 | 824 |
| Short-term debt | 702 | 769 | 2 564 | 2 677 | 2 588 |
| Total debt | 4 981 | 4 069 | 4 387 | 3 849 | 3 412 |
EBITDA margin
20.9%
This company
15.8%
Market median
+32% vs market
20212025
Equity ratio
9.8%
This company
38.2%
Market median
-74% vs market
20212025
Return on equity
338.8%
This company
18.4%
Market median
+1741% vs market
20212025
Net profit margin
12.8%
This company
8.1%
Market median
+58% vs market
20212025
Asset turnover
2.60×
This company
1.12×
Market median
+132% vs market
20212025
Debt / equity
9.22×
This company
0.62×
Market median
-1387% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Gtf Holding As
ORLMED AS Board members of ORLMED AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Geir Thorvald Follestad | Chairman | 0 companies |